Oramed Pharmaceuticals
ORMP
$2.30
Share price
-1.29%
Change (1 day)
-36.64%
Change (1 year)
Categories
Oramed Pharmaceuticals (ORMP) - Total debt
Total debt on the balance sheet as of December 2023 : $51.62 M
According to Oramed Pharmaceuticals's latest financial reports the company's total debt is $51.62 M. A company’s total debt is the sum of all current and non-current debts.
Oramed Pharmaceuticals - Total debt on balance sheet (from 2007 to 2023)
Total debt by year
| Year | Total debt | Change |
|---|---|---|
| 2023-12-31 | $51.62 M | 5674.27% |
| 2022-12-31 | $0.89 M | |
| 2021-08-31 | $0.53 M | 610.67% |
| 2020-08-31 | $0.07 M | |
| 2019-08-31 | $N/A | |
| 2007-08-31 | $0.27 M |
Total debt for similar companies or competitors
| Company | Total debt | differencediff. | Country |
|---|---|---|---|
 Novo Nordisk NVO | $3.89 B | 7,448.70% | 🇩🇰 Denmark |
 Sanofi SNY | $20.36 B | 39,354.30% | 🇫🇷 France |
 Ultragenyx RARE | $43.16 M | -16.37% | 🇺🇸 USA |
 Lexicon Pharmaceuticals
LXRX | $0.10 B | 105.46% | 🇺🇸 USA |
 Compugen CGEN | $1.35 M | -97.38% | 🇮🇱 Israel |